{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:39:29Z","timestamp":1773779969551,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000801","name":"Bayer Healthcare","doi-asserted-by":"publisher","award":["WH-2010-9"],"award-info":[{"award-number":["WH-2010-9"]}],"id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.contraception.2018.11.018","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T02:32:09Z","timestamp":1543890729000},"page":"251-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs"],"prefix":"10.1016","volume":"99","author":[{"given":"Carolina Sales","family":"Vieira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Pack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2018.11.018_bb0005","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.0000000000003637","article-title":"Predictors of unintended pregnancy in women with epilepsy","volume":"88","author":"Herzog","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2018.11.018_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.seizure.2015.02.011","article-title":"Differential impact of antiepileptic drugs on the effects of contraceptive methods on seizures: Interim findings of the epilepsy birth control registry","volume":"28","author":"Herzog","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.contraception.2018.11.018_bb0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0020","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2018.11.018_bb0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2016.02.024","article-title":"Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A","volume":"93","author":"Rowe","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0030","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000001106","article-title":"Committee opinion no. 642: increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy","volume":"126","author":"Committee on Gynecologic Practice Long-Acting Reversible Contraception Working Group","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.11.018_bb0035","series-title":"Mirena product monograph","author":"Bayer Pharma AG","year":"2018"},{"issue":"101","key":"10.1016\/j.contraception.2018.11.018_bb0040","first-page":"e1","article-title":"Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies","volume":"2014","author":"Apter","year":"1656","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2018.11.018_bb0045","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.contraception.2007.01.020","article-title":"Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action","volume":"75","author":"Ortiz","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","article-title":"Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.11.018_bb0055","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/epi.13559","article-title":"Women with epilepsy initiating a progestin IUD: A prospective pilot study of safety and acceptability","volume":"57","author":"Davis","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2018.11.018_bb0060","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"key":"10.1016\/j.contraception.2018.11.018_bb0065","series-title":"WHO | Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.contraception.2018.11.018_bb0070","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijgo.2016.03.015","article-title":"Neurologist knowledge about interactions between antiepileptic drugs and contraceptive methods","volume":"134","author":"Suto","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2018.11.018_bb0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/postgradmedj-2016-134191","article-title":"Update on management of epilepsy in women for the non-neurologist","volume":"92","author":"Gooneratne","year":"2016","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.contraception.2018.11.018_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0010-7824(87)90024-2","article-title":"Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2)","volume":"35","author":"Olsson","year":"1987","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0010-7824(98)00102-4","article-title":"Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants","volume":"58","author":"Alvarez","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0090","series-title":"Bayer report A01291 (LE00607-20910-01): pre-study validation of a radioimmunoassay for quantitative determination of levonorgestrel in human serum","author":"Bayer Pharma","year":"2000"},{"key":"10.1016\/j.contraception.2018.11.018_bb0095","series-title":"Bayer report A05720 (LE00607-21723-01): partial validation of a radioimmunoassay for the quantitative determination of levonorgestrel (LNG) in human serum","author":"Bayer Pharma","year":"2002"},{"key":"10.1016\/j.contraception.2018.11.018_bb0100","series-title":"Bayer report A06302 (LE00607-21724-01): validation of a radioimmunoassay for quantitative determination of levonorgestrel in monkey serum using a gas chromatographic mass spectrometric method as a reference method","author":"Bayer Pharma","year":"2002"},{"key":"10.1016\/j.contraception.2018.11.018_bb0105","series-title":"Syrinx Bioanalytics Oy: validation study report 2011024-02: Validation of LNG (BAY 86-5028, ZK 18206) stability","author":"Syrinx Bioanalytics","year":"2016"},{"key":"10.1016\/j.contraception.2018.11.018_bb0110","series-title":"Syrinx Bioanalytics Oy: Validation study report 2014012-01: Method validation of SHBG TR-FIA in human serum","author":"Syrinx Bioanalytics","year":"2018"},{"key":"10.1016\/j.contraception.2018.11.018_bb0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2018.11.018_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.11.018_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2006.08.012","article-title":"Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials","volume":"75","author":"Mishell","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.contraception.2012.01.015","article-title":"Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system","volume":"86","author":"Seeber","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.contraception.2018.11.018_bb0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0010-7824(90)90035-T","article-title":"Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device","volume":"41","author":"Xiao","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199528030-00003","article-title":"Levonorgestrel. Clinical pharmacokinetics","volume":"28","author":"Fotherby","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2018.11.018_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","article-title":"Interactions between antiepileptic drugs and hormones","volume":"28","author":"Svalheim","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.contraception.2018.11.018_bb0155","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.beem.2013.06.007","article-title":"Principles and pitfalls of free hormone measurements","volume":"27","author":"Faix","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2018.11.018_bb0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2018.11.018_bb0165","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A reappraisal of testosterone\u2019s binding in circulation: physiological and clinical implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2018.11.018_bb0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/jc.2003-030680","article-title":"Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods","volume":"89","author":"Miller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2018.11.018_bb0175","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.contraception.2017.01.004","article-title":"Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index","volume":"95","author":"Praditpan","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0185","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/humrep\/deu089","article-title":"A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives","volume":"29","author":"Modesto","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2018.11.018_bb0190","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.11.018_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2018.11.018_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.contraception.2012.08.022","article-title":"Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies","volume":"87","author":"Jensen","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2007.09.006","article-title":"Subject and clinician experience with the levonorgestrel-releasing intrauterine system","volume":"77","author":"Jensen","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0210","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1093\/humrep\/del264","article-title":"The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women \u2014 effects on bleeding patterns, ovarian function and genital shedding of HIV","volume":"21","author":"Heikinheimo","year":"2006","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.contraception.2018.11.018_bb0215","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2018.11.018_bb0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0010-7824(96)00189-8","article-title":"Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system","volume":"54","author":"Suvisaari","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.11.018_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01849748","article-title":"Three years\u2019 experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: a randomized comparative study","volume":"8","author":"Wang","year":"1992","journal-title":"Adv Contracept"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418305201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418305201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:42:20Z","timestamp":1565246540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782418305201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0010782418305201"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2018.11.018","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2018.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}